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DNA synthesis assessed by 3H thymidine incorporation 
was measured in lymphocytes from patients with pso-
riasis receiving photochemotherapy with 8-methoxy-
psoralen (8-MOP) and UV -A (PUV A). The emission from 
the UV A source contained sufficient short wavelengths 
(UV-B) to impair 3H-thymidine incorporation but could 
be screened out with clear plastic screens. When lym-
phocytes were irradiated in vitro in a lfto dilution of 
plasma containing 8-MOP, increasing doses ofUV -A pro-
duced progressive inhibition of phytohaemagglutinin 
(PHA)-induced DNA synthesis. Cells from patients given 
several previous treatments were inhibited significantly 
more than those from patients receiving their first ex-
posure. This was also true for unirradiated cells sug-
gesting either an accumulation of 8-MOP within cells, 
persistence of DNA damage or alteration of the lympho-
cyte population. 
Lymphocytes removed immediately after patients 
were irradiated showed less 3H thymidine incorporation 
than cells taken just prior to irradiation, which confirms 
that PUV A treatment exerts in vivo effects on circulating 
lymphocytes. 
Photochemotherapy with 8-methoxypsoralen (8-MOP) and 
long wavelength ultraviolet light (UV -A), (PUV A) is rapidly 
becoming established as a treatment for certain skin diseases, 
especially psoriasis. There is evidence, however, that th e pho-
tochemical reaction which intelferes with DNA replication, can 
induce mutations in cultured cells [1] and carcinomatous 
changes in mouse skin (2,3]. It is clearly of great importance 
therefore, that DNA damage induced by PUV A should be 
investigated in man. 
About 45% of UV -A at 365 nm penetrates the epidermis [ 4). 
Kraemer and Weinstein [5) estimated that circulating lympho-
cytes would receive about 1-5% of the skin surface dose as they 
pass through the skin during irradiation and t h ey found a 
reduction in spontaneous incorporation of 3H thymidine into 
DNA of lymphocytes taken immediately after patients had 
received PUV A therapy. 
The purpose of this investigation was to measure the effects 
on DNA synth esis in blood lymphocytes of exposme to 8-MOP 
and UV -A in vitro and to examine the circulating lymphocytes 
from patients receiving PUVA therapy for evidence of DNA 
damage in vivo. 
MATERIALS AND METHODS 
Patients 
Forty-two patients with psoriasis who had entered an MRC trial of 
photochemotherapy with 8-MOP and UV-A (6] agreed to participate 
in this study. Blood was taken from most patients when they attended 
for their ftrst treatment, although in some cases it was taken only after 
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they had received between 4 and 24 treatments (median 14); the median 
dose of UV-A was 49.5 J/cm2 (range 6.5-158 J /cm2). 
Cell Preparation 
Peripheral blood obtained from the antecubital vein was anticoagu-
lated with preservative-free heparin (10 un.its/ rnl) (Evans) . The blood 
was layered onto a mixture of Ficoll/ Isopaque (S.G.l.077) [7] and 
centrifuged at 400 g for 25 min. Bands of lymphoid cells were collected, 
washed 3 times in cold PBS, resuspended in RPMI 1640 (Flow) supple-
men ted with either Yw pooled normal human serum or Yw autologous 
plasma which contained 8-MOP. Cells were dispensed into flat-bot-
tomed wells of micro titre trays (Linbro) in triplicate. More than 95% of 
cells were viable as judged by trypan blue exclusion. The preparation 
procedure lasted 2 to 21/., hl'. When cells were to be irradiated in. vitro 
2.5 x 10'' per well were dispensed in 33.3 11l volumes; after irradiation 
medium was added to bring the final volume to 250 f.Ll. Cells from 
irradiated patients were also seeded at 2.5 X 10'' per well but in 250 f.Ll 
volumes. At all times cells were shielded from direct sunlight and 
"daylight" fluorescent lights. 
Irradiation 
Trays containing lymphocytes were irradiated in a Waldmann PUVA 
4000 machine which contained Sylvania Lifeline F.R.90 Tl2/PUVA/ 
HO fluorescent tubes with peak emission at 365 nm. The mean in tens ity 
of 5 mw/cm2 was recorded by the built in radiometer. The UV dose 
was varied by altering the time of exposure in relation to the emission 
intensity according to dose tables. Although the maximal emission was 
between 320 and 400 nm, the lamps also emitted light of shorter 
wavelengths. After the initial studies all experiments were done with 
trays covered by clear, MylaT-backed, adhesive sealers (Flow) which 
transmitted only 44% of wavelengths shorter than 310 nm but 65 % of 
wavelengths longer than 320 nm. Trays were wrapped in a sleeve of 
aluminium foil so that rows could be exposed sequentially by sliding 
the sleeve back. Except dming irradiation, trays were kept in the dark 
and were handled in a photographic darkroom. 
Treatment with 8-MOP in Vitro 
Preliminary experiments were performed to study the effects of a 
known amount of8-MOP. Recrystallized 8-MOP was supplied by Stiefel 
laboratories. Although known to be rather insoluble in water, 5 mg was 
found to dissolve completely in 250 ml of water after overnight stirring. 
Prior to irradiation, 8-MOP was added to cells resuspended in normal 
serum to a final concentration of 0.02 f.Lg/ rnl which corresponded to a 
'lw dilution of plasma which contained therapeutic levels of about 0.2 
f.Lg/ml. 
To observe the effects of levels of 8-MOP in patients' plasma after 
ingestion of 8-MOP, lymphocytes were irradiated in parallel cultures 
that contained a Yw dilution of autologous plasma or normal human 
serum. 
For observations on the effects of PUV A in vivo lymphocytes were 
collected just before and again immediately after patients had received 
irradiation. They were cultured in normal serum. 
Patients receiving PUV A therapy were given 8-MOP orally (0.6 mg/ 
kg) 2 hr before irradiation. 
DNA Synthesis 
In most experiments DNA synthesis was stimulated by addition of 
phytohaemagglutinin (PHA purified, HA 16, Wellcome Reagents) at a 
final concentration of 1 f.Lg/rnl in a final volume of 275 f.Ll. After 44h 
incubation at 37°C in a humidified atmosphere of 5% C02 in air, 0.2 f.LC 
of tritiated thymidine (Sp. act 2Ci/mmol, Amersham) was added for a 
further 4 hr. Cultures were terminated by aspiration onto glass fiber 
discs in a cell harvester (Mash II, Microbiological Associates). The 
discs were washed with distilled water, dried and counted in a Packard 
liquid scintillation spectrometer. 
The geometric means of counts per minute from triplicate cultures 
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were calculated. Dose response cu1·ves were plotted with log10 counts 
per minute; curves were compared by analysis of variance. Paired 
samples were compared by means of paired t-tests applied to the log ,o 
counts per minute. 
RESULTS 
Effect on Lymphocyte DNA Synthesis of Exposure to UV 
Light A lone 
A s a control for the effects of UV light alone on lymphocytes 
fro m patients who had not received PUV A treatment, cells 
from 12 patients were irradiated in uncovered trays, PHA was 
added and 3H thymidine incorporation determined. DNA syn-
thesis was found to diminish sharply with increasing doses of 
UV (Fig 1) . This was discovered to be due to the presence of 
UV-B since no change in 3H thymidine incorporation occurred 
when the trays were covered during irradiat ion with adhesive 
sealers which allowed poor transmission of wavelengths longer 
t han 310 nm and thus screened out most UV-B (Fig 1). 
Effect on Lymphocyte DNA Synthesis of Exposure to UV-A 
in Presence of 8-MOP in Vitro 
To establish the characteristics of the inhibitory effect on 
PHA-induced DNA synthesis of UV-A in the presence of 8-
MOP, lymphocytes from 10 patients with psoriasis who had not 
started treatment with PUV A were suspended in medium to 
w hich was added 0.02 11g/ ml 8-MOP; cells were exposed to 
varying doses of irradia tion. Increasing doses of UV -A produced 
progressive inhibition of 3H thymidine incorporation (Fig 1). 
To examine the effects of 8-MOP present in plasma of pa-
tients receiving PUV A therapy, blood was collected 2 hr after 
ingestion of the drug from 7 patients receiving t heir first dose 
and from 6 patients who had received between 4 and 24 previous 
treatments. The lymphocytes were irradiated with UV -A in 
parallel cultures in Y10 normal serum and 1/ to patients' own 
plasma which contained 8-MOP. When irradiated in 8-MOP 
con taining plasma, cells from patients receiving their first treat-
ment showed similar inhibition of PHA-induced DNA synthesis 
to cells irradiated in the presence of 0.02 11g/ml of 8-MOP (Fig 
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FIG 1. Effect of UV-A alone and UV-A combined with UV-B on 
PHA-induced DNA synthesis by lymphocytes. Incorporation of "H 
thymidine is expressed as log10 counts/min/ culture. Points are geomet-
ric means ± SEM - 0 - = results for cell irradiated in uncovered trays, 
i.e., combined UV -A and UV -B. - e- = results for cells irradiated 
through cleru· sealer, i.e., UV-A alone - X- = results for cells irradiated 
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FIG 2. Inhibition of DNA synthesis in lymphocytes exposed to 8-
MOP and UV-A in vitro. Points are geometric means ± SEM- x- = 
cells irradiated in presence of 0.02 fLg/ ml 8-MOP (as in Fig 1). - e- = 
cells from 7 patients given 8-MOP for first time, irradiated in plasma 
which contained 8-MOP.- 0 - = cells from 7 patients given 8-MOP for 
first time, irradiated in normal serum. - A - = cells from 6 previously 
treated patients, irradiated in plasma which contained 8-MOP. - 6 -
= cells from 6 previously treated patients, irradiated in normal serum. 
Cells from previously treated patients gave lower "H thymidine incor-
poration and were inhibited significantly more than those from patients 
receiving their first treatment (p < 0.01 by analysis of variance). 
significantly less thymidine incorporation (p < 0.01 by analysis 
of variance) (Fig 2). When irradiated in normal serum there 
was virtually no inhibition of 3H thymidine incorporation by 
lymphocytes from either group (Fig 2) although cells from 
previously treated patients gave slightly lower Incorporation. 
It was also observed that when cultured in normal serum 
without 8-MOP even unirradiated cells from previously treated 
patients were less responsive to PHA than those from patients 
receiving their first dose (geom etric m ean ± SEM 4.0042 ± 
0.0563 cpm and 4.1332 ± 0.1228 cpm respectively. (Fig 2). The 
difference was more marked when cells were cultw-ed in pa-
tients' own plasma which contained 8-MOP (3.8514 ± 0.1158 
cpm and 4.098 ± 0.1366 cpm respectively). 
Persistence of Activity of 8-MOP in Plasma 
To observe the duration of persistence of active levels of 8-
MOP, blood was taken from 5 patients 2 and 24 ru· after 
ingestion. This was the first dose for 3 patients, the 12th for one 
and the 22nd for one. Lymphocytes were irradiated in a 1/ to 
dilution of patients' plasma which contained 8-MOP, obtained 
at the same time as the cells. When blood was taken at 2 hr, 
cells fTom the 2 previously treated patients gave less 3H thy-
midine incorporation than cells from patients receiving their 
first treatment (Fig 3) . However, by 24 ru· after ingestion the 
difference was much reduced and cells from both groups gave 
a normal 3H thymidine incorpora tion; in addition no inhibition 
of DNA synthesis by UV-A was demonstrable in cells from 
either group at that time. Thus activity of 8-MOP was not 
detectable in plasma 24 hr after ingestion. 
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Effect of Exposure to UV-A in Vivo after Ingestion of 8-MOP 
To examine the effect of 8-MOP and UV -A in viuo, lympho-
cytes were collected from patients who had ingested 8-MOP just before and again immediately after patients received irra-
diation . Cells were cultured in a 1/ 10 dilution of normal serum 
for 48 hr; 3H thymidine incorporation was measured in unstim-
ulated and PHA stimulated cultures. Cells taken after irradia-
tion from 10 patients given th eir frrst treatment with PUV A 
gave lower levels of both spontaneous and PHA-induced ''H 
t hymidine incorporation compared with cells taken before pa-
tients were irradiated (Table) although the differences do not 
quite attain significance. Cells taken just after irradiation from 
patients who had already received several treatments also gave 
less 3H thymidine incorporation in both unstimulated and PHA 
containing cultures but again the differences did not attain 
significance (Table). Cells removed prior to irradiation from the 
previously treated patients gave significantly lower PHA-in-
duced incorporation of 3H thymidine than cells taken prior to 
irradiation from patients about to receive their fu·st t reatment 
(p < 0.05, Table). Cells taken after irradiation showed a similar 
difference (p < 0.05, Table). 
In addition to the pre- and postirradiation observations on 
the 18 patients shown in the Table, PHA-induced responses of 
lymphocytes taken before patients received irradiation were 
measured in a further 3 patients who had had several previous 
treatments and in 11 additional patients receiving their first 
dose of 8-MOP. When the comparison between previously 
treated patients and those receiving their frrst treatment was 
extended to include data from these additional patients, the 
differences became even more significant. The geometric mean 
for cells from the total of 11 previously treated patients was 
8425 ct/min (range of SEM 7406-9585); the geometric mean for 
the total of 21 previously untreated patients was 15,108 ct/rnin (13,662-16,707) (p < 0.005 by Student's t-test). Thus cells from 
patients who have had several previous treatments clearly have 
an impaired ability to synthesize DNA when stimulated with 
PHA. There was no correlation between the number of previous 
treatments and the reduction of lymphocyte responses. 
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FIG 3. Duration of persistence of 8-MOP activity in plasma. Blood 
was taken from 5 patients 2 and 24 hr after ingestion of 8-mop. 
Lymphocytes were irradiated in patients' plasma which contained 8-
MOP, 3H thymidine incorporation was stimulated with PHA. a, geo-
metric means for 3 patients receiving first treatment. b, geometric 
means for patients receiving 12th and 22nd treatments. 
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Effect of in vivo treatment with 8-MOP and UV-A on incorporation 
oeH thymidine into DNA by lymphocytes from p atients with 
psoriasis 
Spontaneous PHA stimulated 
Source of DNA synthesis DNA synthesis 
lymphocytes Pre- Post- Pre- Post-
irradiatio n irradiation irradiation irrad iation 
Patients receiving 132 111 16,151 14,494 
1st dose of PUV A (156-110) (130-94) (19,489- (16,912-
(n = 10) 13,384) 12,422) 
Patients already 114 54 8,664" 5,936" 
treated several (163-79) (72-41) (10,342- (8,778-
times (n = 8) 7,258) 5,936) 
Figures are geometric mean coun ts per minute with range of SEM in 
brackets. 
"Significantly lower than in ceUs from patients receiving first treat-
ment. p < 0.05, Student's t-test applied to geometric means. 
DISCUSSION 
The photochemical interaction between 8-MOP and DNA in 
the presence of UV light at 365 nm has been studied in various 
cellular systems in vitro by many workers [1,8-11]. However, 
the effects in man of repeated exposure to 8-MOP and the UV 
emission from PUV A treatment lamps has so far received 
comparatively little attention. Results presented here which 
show that lymphocytes from patients who have had several 
previous treatments show reduced responsiveness to PHA, sug-
gest that the effects of exposure to PUV A may be of longer 
duration and greater significance than was thought previously. 
It was surprising to find in preliminary experiments that 3H 
thymidine incorporation by lymphocytes was inhibited by the 
emission of the PUVA lamps in the absence of 8-MOP. This 
inhibition was shown to be caused by UV-B as when cells were 
irradiated through a transparent screen which transmitted 
mainly wavelengths longer than 310 nm, the effect was abol-
ished. Since the lamps' emission contained only a small propor-
tion of wavelengths shorter than 310 nm the 20% reduction of 
transmission by the Mylar was presumably sufficient to elimi-
nate their effect. Whether the amount of UV -B emitted from 
PUV A lamps contributes to the therapeutic effect in patients 
by an additive or synergistic action with UV-A and 8-MOP is 
unclear. 
The present resul ts show that when cells were irradiated in 
a 1/w dilution of plasma from patients who had ingested their 
frrst dose of 8-MOP, there was an inhibition of DNA synthesis 
which was closely comparable with than obtained by the addi-
tion of 0.02 Jlg/ ml of 8-MOP. Scherer and co-authors [11] 
described similar inhibition of DNA synthesis but their concen-
trations of 1-3 }lg/ ml were based on the assumption that the 
contents of the commercial capsules which they dissolved were 
pure 8-MOP. 
The possibility that circulating leukocytes might sustain 
DNA damage during PUVA treatment was demonstrated by 
Kraemer and Weinstein [5). They found that in 7 of 13 cases, 
leukocytes removed immediately after patients received i.rra-
diation exhibited significantly lower incorporation of 3H thy-
midine after 90 min culture than cells taken before patients 
were irradiated. The findings presented here on cells from 
patients receiving their first treatment show this is also true for 
both unstimulated 3H thymidine incorporation measured at 48 
hr and also for PHA-induced DNA synthesis. Since this inhi-
bition was also found in 5 of 8 patients who had received several 
previous treatments, it appears that pigmentation which devel-
ops as treatment progresses, does not confer protection on 
circulating lymphocytes presumably because the dose of UV -A 
is also increased. 
The findings presented here demonstrate that after ingestion 
the persistence of 8-MOP in plasma is of only short duration; 
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activity of 8-MOP was not detectable after 24 hr. The results 
also show that repeated exposure to 8-MOP and UV light exerts 
a c umulative effect on lymphocyte responsiveness. After pa-
tien ts had received several treatments they lymphocytes, even 
when unirradiated, gave significantly lower 3H thymidine in-
corporation when stimulated with PHA. These results are at 
variance with those of Harper et a l [12] who found no differ-
ences in PHA-induced responses of unstimulated thymidine 
incorporation in lymphocytes from patients receiving mainte-
nance therapy compared with nonpsoriatic controls. On the 
other hand t he present findings support those of Morison and 
co-workers [13] who observed a reduction in lymphocyte re-
sponses to PHA early in the course of PUV A treatment and 
again later in the maintenance period. Possible reasons for t he 
lack of agreement include the different culture and labeling 
conditions employed by different workers and the fact that the 
observations of Harper et al were made in patients receiving 
maintenance rather than clearing therapy [12]. 
The reduced lymphocyte responsiveness to PHA reported 
here may be accounted for by a number of factors. Firstly, 8-
MOP may remain bound to cells . Thus the lower responses 
given by cells from previously treated patients might reflect 
their greater sensitivity to the small amounts of ambient light 
to which they were exposed during separation and washing. 
Against this however, is the observation that after washing 
cells, UV -A failed to inhibit 3H thymidine incorporation by cells 
irradiated in normal serum-which suggests that if 8-MOP was 
present in cells it was only loosely bound. 
A second possibility is cumulative DNA damage which is not 
fully repaired between treatments. The mechanisms for repair 
of DNA damage produced by 8-MOP and UV-A are not yet 
fully elucidated. Excision repair mechanisms have been impli-
cated [8], so too has the error-prone process of postreplication 
repair [5]. Indeed, lymphocytes exposed to PUVA, either in 
vitro [9] or in vivo [10] exhibited increased numbers of sister 
chromatid exchanges which may be a manifestation of postrep-
lication repair. The repair of interstrand crosslinks formed by 
8 -MOP in the presence of UV-A appears to be a slow process; 
in guinea pig skin only 25% of such crosslinks were repaired by 
72 hr [14). It seems quite likely therfore, that DNA damage in 
lymphocytes from patients receiving PUV A therapy thrice 
weekly is not fully repaired between doses. 
A third explanation is that PUV A therapy exerts differential 
effects on various subpopulations of lymphocytes. Thus, after 
several treatments the proportion of circulating lymphocytes 
t h at respond to PHA (i.e., T cells) might be substantially 
altered. Ionizing radiation [14] and short wavelength UV light 
[15] are known to exert differential killing effects on certain 
s ubpopulations oflymphocytes and it is possible the same could 
be true for PUV A. There are several reports on the effects of 
PUV A therapy on T cell proportions [12,13,17,18]. Some au-
t hors have noted an initial decrease in the proportion ofT cells 
[1 7,18) although others have not [12,13]. Unfortunately actual 
numbers of T cells were not reported by Cormane et al [17], 
Haftek et al [18] or Harper et al [12] and alterations in propor-
tion may be due to changes in the numbers of lymphocytes 
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other than T cells. In addition Morison and co-workers (13] 
found no changes in actual T cell numbers although a decrease 
in lymphocyte responses to PHA occurred. It seems likely 
therefore, that lymphocyte DNA was damaged and hence their 
proliferative capacity impaired . 
Direct studies are now required to dist inguish between these 
possibilit ies because of their implications for carcinogenesis and 
immunological dysfunction, in the course of PUV A therapy. 
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